Texas Business Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Texas Business Times.

Press releases published on October 7, 2026

Oct. 7, 2026

Gilat Secures Over $10 Million in Additional SkyEdge IV Orders from a Leading Satellite Operator

Indeterminate GlobeNewswire

Oct. 7, 2026

Lantronix CEO to Meet with Investors and Defense Customers at AUSA 2026

Indeterminate GlobeNewswire

Oct. 7, 2026

Kane Biotech to Present Clinical Data and Showcase revyve® Product Line at SAWC Fall 2026

Indeterminate GlobeNewswire

Oct. 7, 2026

Zenas BioPharma Announces Upcoming Presentations of Orelabrutinib Data in Relapsing Remitting Multiple Sclerosis, Clinical Trial Designs in Progressive Multiple Sclerosis and Other Multiple Sclerosis Portfolio Data at MSToronto2026

Indeterminate GlobeNewswire

Oct. 7, 2026

VERAXA Biotech Provides Overview on Implementation of FDA-Aligned Human-Relevant Models into R&D Strategy

Indeterminate GlobeNewswire

Oct. 7, 2026

Marex announces changes to Group Board

Indeterminate GlobeNewswire

Oct. 7, 2026

Noah Closes $38m Seed Funding Round as Major Enterprises Move Cross-Border Payments onto Stablecoin

Indeterminate GlobeNewswire

Oct. 7, 2026

Freight Right Launches MCP, Bringing Freight Quoting, Tracking and Booking Into AI Assistants

Indeterminate GlobeNewswire

Oct. 7, 2026

Cadrenal Therapeutics Retains Tungsten Advisors to Lead Formal Strategic Process to Maximize Value of its Orphan Thrombo-Inflammatory Therapeutics

Indeterminate GlobeNewswire

Oct. 7, 2026

Capital City Bank Group, Inc. to Announce Quarterly Earnings Results on Tuesday, October 20, 2026

Indeterminate GlobeNewswire

Oct. 7, 2026

Matchpoint Therapeutics Announces $150 Million Series B Financing to Advance Pipeline of First-In-Class Oral Small Molecules for Autoimmune and Inflammatory Diseases

Indeterminate GlobeNewswire

Oct. 7, 2026

Sono-Tek Announces Fiscal Second Quarter and First Half 2027 Earnings Conference Call

Indeterminate GlobeNewswire

Oct. 7, 2026

Atavistik Bio to Present at the Cure HHT 16th International Scientific Conference

Indeterminate GlobeNewswire

Oct. 7, 2026

Arvinas Shares Novel Oculomotor and Biomarker Data from Phase 1 Clinical Trial of ARV-102 in Patients with Parkinson’s Disease

Indeterminate GlobeNewswire

Oct. 7, 2026

Badass Capital Fund I Reports 39.92% Net Return In Q3 2026

Indeterminate GlobeNewswire

Oct. 7, 2026

Premier American Uranium Reports 10 ft of 0.064% eU₃O₈ in Ongoing Drilling at Kaycee, Wyoming

Indeterminate GlobeNewswire

Oct. 7, 2026

Amplify ETFs Launches Top 10™ Semiconductors ETF (CPU), Expanding Top 10™ Suite

Indeterminate GlobeNewswire

Oct. 7, 2026

Axsome Therapeutics to Report Third Quarter 2026 Financial Results on November 2

Indeterminate GlobeNewswire

Oct. 7, 2026

OR Royalties Announces Preliminary Q3 2026 GEO Deliveries

Indeterminate GlobeNewswire

Oct. 7, 2026

Redevances OR annonce ses livraisons préliminaires d’OEO pour le troisième trimestre de 2026

Indeterminate GlobeNewswire